Shopping Cart 0
Cart Subtotal
USD 0

Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Medical Devices Pipeline Assessment, 2018 provides an overview of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Overview 7

3 Products under Development 8

3.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Stage of Development 8

3.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Territory 9

3.3 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Regulatory Path 10

3.4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Estimated Approval Date 11

3.5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Ongoing Clinical Trials 12

4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products under Development by Companies 13

4.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies-Pipeline Products by Stage of Development 13

4.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Stage of Development 14

5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies and Product Overview 15

5.1 Andramed GmbH Company Overview 15

5.2 Boston Scientific Corp Company Overview 16

5.3 C. R. Bard Inc Company Overview 18

5.4 Cagent Vascular LLC Company Overview 21

5.5 Contego Medical, LLC Company Overview 22

5.6 Hexacath SA Company Overview 24

5.7 Medtronic plc Company Overview 25

5.8 MicroPort Scientific Corp Company Overview 26

5.9 Minnesota Health Solutions Corporation Company Overview 28

5.10 NuVascular Technologies Inc Company Overview 29

5.11 QT Vascular Ltd Company Overview 30

5.12 SurModics Inc Company Overview 31

5.13 Terumo Corp Company Overview 34

5.14 Terumo Europe NV Company Overview 35

6 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters- Recent Developments 38

6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 38

6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 40

6.3 May 16, 2018: Surmodics Announces Leadership Change and Appointment of Interim CFO 40

6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 41

6.5 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 41

6.6 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 42

6.7 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical 43

6.8 May 03, 2018: Teleflex Reports First Quarter 2018 Results 43

6.9 May 02, 2018: Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 46

6.10 May 02, 2018: CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance 47

6.11 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 48

6.12 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 50

6.13 Apr 23, 2018: Surmodics Announces FDA Clearance of a New .018 Low-Profile PTA Balloon Dilation Catheter 51

6.14 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 52

6.15 Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 52

6.16 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 53

6.17 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 54

6.18 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 56

6.19 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 56

6.20 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 58

6.21 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 59

6.22 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 59

6.23 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 61

6.24 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 63

6.25 Jan 29, 2018: Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices 63

6.26 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 64

6.27 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 66

6.28 Jan 08, 2018: MicroPort Endovascular Attends CEC 2017 66

6.29 Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017 67

6.30 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 68

6.31 Dec 22, 2017: Kaneka releasing a high-pressure balloon catheter to enlarge peripheral vessels 68

6.32 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 69

6.33 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems 70

6.34 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 70

6.35 Dec 04, 2017: Oceanus 14 Pro, PTA balloon catheter receives CE Mark Approval 72

6.36 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 72

6.37 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance 75

6.38 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 76

6.39 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 77

6.40 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results 78

6.41 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 80

6.42 Oct 25, 2017: Bard Announces Third Quarter Results 81

6.43 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 83

6.44 Oct 12, 2017: STENTYS: Revenues for the Third Quarter of 2017: Continued Growth for the Xposition S Stent 84

6.45 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria 84

6.46 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 85

6.47 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 86

6.48 Oct 02, 2017: STENTYS: 2017 half-year results 87

6.49 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 88

6.50 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017 88

6.51 Sep 18, 2017: Surmodics Announces Global Approvals of .014 Low-Profile PTA Balloon Dilation Catheter 89

6.52 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 90

6.53 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 91

6.54 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 94

6.55 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 94

6.56 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 95

6.57 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of USD74.7 million 97

6.58 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 97

6.59 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results 99

6.60 Jul 24, 2017: Reewarm Gains CFDA Approval 100

6.61 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 101

6.62 Jul 12, 2017: STENTYS: Revenues Of 1.7 Million in the Second Quarter Of 2017 101

6.63 Jul 07, 2017: MPSC New COO Glendy Wang on Board 102

6.64 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 102

6.65 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 104

7 Appendix 106

7.1 Methodology 106

7.2 About GlobalData 109

7.3 Contact Us 109

7.4 Disclaimer 109


List Of Figure

1.2 List of Figures

Figure 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Stage of Development 8

Figure 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Territory 9

Figure 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Regulatory Path 10

Figure 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Estimated Approval Date 11

Figure 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Ongoing Clinical Trials 12


List Of Table

1.1 List of Tables

Table 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Stage of Development 8

Table 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Territory 9

Table 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Regulatory Path 10

Table 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Estimated Approval Date 11

Table 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Ongoing Clinical Trials 12

Table 6: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies-Pipeline Products by Stage of Development 13

Table 7: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters-Pipeline Products by Stage of Development 14

Table 8: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 15

Table 9: Zero-Profile PTA Balloon-Product Status 15

Table 10: Zero-Profile PTA Balloon-Product Description 15

Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16

Table 12: Drug Coated Balloon-Below-The-Knee (BTK)-Product Status 16

Table 13: Drug Coated Balloon-Below-The-Knee (BTK)-Product Description 16

Table 14: Next Generation 0.018 Balloon-Product Status 17

Table 15: Next Generation 0.018 Balloon-Product Description 17

Table 16: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Table 17: LUTONIX 035 Drug Coated Balloon PTA Catheter-Long Femoropopliteal Lesions-Product Status 18

Table 18: LUTONIX 035 Drug Coated Balloon PTA Catheter-Long Femoropopliteal Lesions-Product Description 18

Table 19: C. R. Bard Inc-Ongoing Clinical Trials Overview 19

Table 20: LUTONIX 035 Drug Coated Balloon PTA Catheter-Long Femoropopliteal Lesions-A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions 20

Table 21: Cagent Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Table 22: Serranator Bass-Product Status 21

Table 23: Serranator Bass-Product Description 21

Table 24: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 22

Table 25: PALADIN-Product Status 22

Table 26: PALADIN-Product Description 22

Table 27: Superficial Femoral Artery Balloon-Product Status 23

Table 28: Superficial Femoral Artery Balloon-Product Description 23

Table 29: Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview 24

Table 30: MERAK PTA Dilatation Catheter-Product Status 24

Table 31: MERAK PTA Dilatation Catheter-Product Description 24

Table 32: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 33: Chocolate PTA Balloon Catheter-Product Status 25

Table 34: Chocolate PTA Balloon Catheter-Product Description 25

Table 35: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Table 36: Reewarm14-Product Status 26

Table 37: Reewarm14-Product Description 26

Table 38: Reewarm18 Peripheral Balloon Dilation Catheter-Product Status 27

Table 39: Reewarm18 Peripheral Balloon Dilation Catheter-Product Description 27

Table 40: Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 28

Table 41: Balloon Angioplasty Inflation Device-Product Status 28

Table 42: Balloon Angioplasty Inflation Device-Product Description 28

Table 43: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 44: NuSpun DE Balloon-Product Status 29

Table 45: NuSpun DE Balloon-Product Description 29

Table 46: QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Table 47: Silk PTA Balloon Catheter-Product Status 30

Table 48: Silk PTA Balloon Catheter-Product Description 30

Table 49: SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 50: 0.018 OTW Dual Lumen PTA Catheter-Product Status 31

Table 51: 0.018 OTW Dual Lumen PTA Catheter-Product Description 31

Table 52: 0.018 RX Dual Lumen PTA Catheter-Product Status 32

Table 53: 0.018 RX Dual Lumen PTA Catheter-Product Description 32

Table 54: 0.035 Large Diameter OTW PTA Catheter-Product Status 32

Table 55: 0.035 Large Diameter OTW PTA Catheter-Product Description 33

Table 56: 0.035 Next Generation Workhorse PTA Catheter-Product Status 33

Table 57: 0.035 Next Generation Workhorse PTA Catheter-Product Description 33

Table 58: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 34

Table 59: TRI PTA Balloon-Product Status 34

Table 60: TRI PTA Balloon-Product Description 34

Table 61: Terumo Europe NV Pipeline Products & Ongoing Clinical Trials Overview 35

Table 62: Kanshas Drug Coated Balloon-Product Status 35

Table 63: Kanshas Drug Coated Balloon-Product Description 35

Table 64: Terumo Europe NV-Ongoing Clinical Trials Overview 36

Table 65: Kanshas Drug Coated Balloon-Prospective, Multi-Center, Open, Single Arm Study for the Treatment of Patients Presenting De Novo Lesions in the Superficial Femoral or Popliteal Arteries Using a Kanshas Drug Coated Balloon Catheter 37

Table 66: Glossary 108

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Andramed GmbH, Zero-Profile PTA Balloon; Boston Scientific Corp, Drug Coated Balloon - Below-The-Knee (BTK); Boston Scientific Corp, Next Generation 0.018 Balloon; C. R. Bard Inc, LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions; Cagent Vascular LLC, Serranator Bass; Contego Medical, LLC, PALADIN; Contego Medical, LLC, Superficial Femoral Artery Balloon; Hexacath SA, MERAK PTA Dilatation Catheter; Medtronic plc, Chocolate PTA Balloon Catheter; MicroPort Scientific Corp, Reewarm14; MicroPort Scientific Corp, Reewarm18 Peripheral Balloon Dilation Catheter; Minnesota Health Solutions Corporation , Balloon Angioplasty Inflation Device; NuVascular Technologies Inc, NuSpun DE Balloon; QT Vascular Ltd, Silk PTA Balloon Catheter; SurModics Inc, 0.018 OTW Dual Lumen PTA Catheter; SurModics Inc, 0.018 RX Dual Lumen PTA Catheter; SurModics Inc, 0.035 Large Diameter OTW PTA Catheter; SurModics Inc, 0.035 Next Generation Workhorse PTA Catheter; Terumo Corp, TRI PTA Balloon; Terumo Europe NV, Kanshas Drug Coated Balloon


Companies

Andramed GmbH

Boston Scientific Corp

C. R. Bard Inc

Cagent Vascular LLC

Contego Medical, LLC

Hexacath SA

Medtronic plc

MicroPort Scientific Corp

Minnesota Health Solutions Corporation

NuVascular Technologies Inc

QT Vascular Ltd

SurModics Inc

Terumo Corp

Terumo Europe NV